share_log

Intelligent Bio Solutions | 4: Statement of changes in beneficial ownership of securities-Officer Simeonidis Harry

SEC ·  Sep 28 05:05

Summary by Futu AI

Harry Simeonidis, the Chief Executive Officer of Intelligent Bio Solutions Inc. (INBS), was granted 40,000 shares of common stock on September 25, 2024. The transaction, which was completed on the same day, was a grant and did not involve any monetary transaction, as the shares were acquired at a price of $0.00. Following this transaction, Simeonidis's direct holdings in the company increased to a total of 40,408 shares of common stock.
Harry Simeonidis, the Chief Executive Officer of Intelligent Bio Solutions Inc. (INBS), was granted 40,000 shares of common stock on September 25, 2024. The transaction, which was completed on the same day, was a grant and did not involve any monetary transaction, as the shares were acquired at a price of $0.00. Following this transaction, Simeonidis's direct holdings in the company increased to a total of 40,408 shares of common stock.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated